RxDoctor Payments Data

Leander Cannick, MD

Radiation Oncology · Anderson, SCNPI 1881705671

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 53 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations.

$3,207in general payments, 2019–2025

Across 161 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$334
  • Eisai Inc.$245
  • AstraZeneca$213
  • Seagen Inc.$162
  • Johnson & Johnson$139
  • Boston Scientific$138
  • plus $2K from 47 others

What the payments were for

  • Food & beverage$3,196100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,207 in reported general payments places this provider in the 85th percentile of 72 radiation oncology providers in South Carolina.

See all radiation oncology providers in South Carolina

Medicare billing

Part B allowed, 2024
$252,136
Medicare patients
240
Services billed
2,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate18$857
Silver Sulfadiazine23$582
Tamsulosin Hcl38$360
SsdSilver Sulfadiazine12$254

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →